Technological advances are helping shape the dosage forms of the future.

The Shape of Dosage Forms

CDMOs offer expertise and capacity for spray drying.

Spray Drying Finds Growing Use for ASDs

Workforce training is crucial for biopharmaceutical manufacturing.

Single-Use System Training 

Topic

Articles

Lubrizol has launched Apisolex technology to improve solubility and simplify the manufacturing of parenteral drug products.

Lubrizol Launches Apisolex Technology 

AstraZeneca's recombinant COVID-19 vaccine, originally invented by the University of Oxford, has been approved as a third dose booster vaccine in the EU.

Vaxzevria Gains Approval in EU as a Third Dose COVID-19 Booster in Adults

EMA has recommended the marketing authorization of Xenpozyme (olipudase alfa) in the European Union. 

EMA Recommends Approval of Niemann-Pick Disease Types A/B and B Therapy

Laxman Shetty is the vice president of operations for ACG.

Jnanadeva Bhat is the vice president of formulation R&D (pharma and nutra) for ACG.

Anita Solanki is the lead for whitepapers and publications, formulation R&D (pharma and nutra), for ACG.

The latest manufacturing technologies are essential for helping pharmaceutical formulators meet up-and-coming trends in OSD treatments. 

Manufacturing OSD Forms: Key Trends Shaping the Industry

Andy Dumelow is PharmaCare manager at I Holland.

By following some fundamental steps, manufacturers can optimize their tablet tooling maintenance and resulting productivity.

Don’t Gamble on Tablet Tooling Maintenance

Feliza Mirasol is the science editor for 

The need for sustainability and early considerations of a lyophilization strategy grow more pertinent on the back of growing biologics volume.

Plan Early: Optimizing Stability During Lyophilization

CGTs offer hope for the future of treatments, but the costly manufacturing, slow turnaround time, and need for supplies hinder progress.

Opportunities for Growth and Breakthroughs for Cell and Gene Therapies

FDA is limiting the use of Janssen’s COVID-19 vaccine to certain individuals.

FDA Limits Use of Janssen COVID-19 Vaccine

Podcasts

In this episode of the Drug Solutions Podcast, Feliza Mirasol, Pharmaceutical Technology’s science editor, discusses technologies enabling biologics and emerging therapies manufacturing and development with Barry Holtz, PhD, chief scientific officer of Phylloceuticals, and Professor Yaakov Nahmias, founder and chief scientific officer, Tissue Dynamics and founder and president, Future Meat Technologies.



Drug Solutions Podcast: Biologic Drug Development and Manufacturing

Scott Whyte is the chief digital officer for AeroSafe Global.

With the majority of large pharmaceutical manufacturers aiming for carbon neutrality by 2030, reusable packaging remains a largely untapped approach in achieving measurable ESG gains.